Casandra
Casandra Test Code QD39768Version 1 (DRAFT)
Performing Lab
Carbamazepine and Metabolite Free
Clinical Use
Order TestUse
Quantification of free (unbound) carbamazepine and its free metabolite in serum or plasma to aid in therapeutic drug monitoring, helping clinicians assess drug levels relative to therapeutic and toxic ranges.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
Carbamazepine Metabolite, Free
AnalyteCarbamazepine Metabolite, Free • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Carbamazepine, Free
AnalyteCarbamazepine, Free • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
2 mL serum
Minimum Volume
1.2 mL
Container
red‑top tube (no gel)
Causes for Rejection
Serum separator tube (SST)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 10 months |
Related Tests
Other tests from different labs that may be relevant
Carbamazepine, Free, Serum
Mayo Clinic Lab
Carbamazepine, Free and Total, Serum or Plasma
ARUP Laboratories
Carbamazepine, Free and Total, Serum
Mayo Clinic Lab
Carbamazepine and 10,11 Epoxide, Unbound, Serum or Plasma
Labcorp
Carbamazepine Profile, Serum
Mayo Clinic Lab
Carbamazepine and Carbamazepine-10,11 Epoxide, Serum or Plasma
Labcorp
Carbamazepine, Serum or Plasma
Labcorp
Carbamazepine, Total (Change effective as of 10/21/24: Refer to 2011763 in the October Hotline)
ARUP Laboratories
Carbamazepine Epoxide and Total
ARUP Laboratories
Carbamazepine-10,11 Epoxide
Labcorp